Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
批准号:
8244451
负责人:
TODD A FEHNIGER
金额:
$11.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-26 至 2014-03-31
关键词:
Activated Natural Killer CellAddressAdvisory CommitteesAntigensBindingBinding SitesCancer PatientCell-Mediated CytolysisCellsCellular biologyCodeCytokine ActivationCytokine SignalingDatabasesDiseaseDoctor of PhilosophyFosteringFoundationsGene Expression ProfileGenerationsGenesGeneticGenetic TranslationGenomicsGoalsHealthHematologic NeoplasmsHematologyHematopoietic NeoplasmsImmuneImmune systemImmunityImmunologic MonitoringIn VitroInstructionInterferonsInternal MedicineLaboratoriesLeadLymphocyteMalignant - descriptorMalignant NeoplasmsMediatingMedicalMedicineMentorsMessenger RNAMicroRNAsMolecularMolecular ProfilingMusNK Cell ActivationNatural Killer CellsPathway interactionsPhysiciansPopulationPost-Transcriptional RegulationPrincipal InvestigatorProtein DatabasesProteinsProteomeProteomicsRegulationResearchRestRoleScientistTechniquesTechnologyTrainingTraining ProgramsTranscriptional RegulationTranslationsUniversitiesVirusWashingtonWorkbasecareercareer developmentcytokinecytotoxiccytotoxicityexperiencegranzyme Bin vivokillingsleukemiamRNA Transcript Degradationmouse modelnoveloncologyparacrinepathogenperforinprogramsprotein expressionprotein profilingresearch study
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The long term goal of this proposal is to train the applicant to become an independent academic physician-
scientist studying the innate immune system and its impact on blood cancers. The principal investigator (PI)
has completed PhD training focused on the cellular biology of natural killer (NK) cells, and MD training in
internal medicine and hematology-oncology. This application describes a 5 year training program that will
provide a mentored educational experience aimed at developing new scientific expertise in molecular
profiling, massively parallel sequencing, proteomic analysis, manipulation of microRNAs (miRs), and the
generation of mouse models. Dr. Timothy Ley will mentor the Pi's scientific and career development. He is
a recognized leader in the field of lymphocyte cytotoxicity, in vivo genetic mouse models, and genomic
analysis of leukemia. Furthermore, an advisory committee of medical scientist experts will provide additional
scientific and and non-scientific career development guidance.
The proposed research will evaluate the role of miRs in the regulation of NK cell cytokine activation.
Recent work by the PI in Dr. Ley's laboratory identified two critical cytotoxic molecules, granzyme B (GzmB)
and perforin (Prf1), that are post-transcriptionally regulated in NK cells. We hypothesize that miRs regulate
GzmB and Prf1 in resting NK cells, and that cytokine-activation releases their block in translation.
To address this hypothesis, we propose the following specific aims:
1) We will define the miR expression profiles in resting and cytokine-activated NK cells, and evaluate
candidate miRs that may regulate GzmB and Prfl mRNA translation.
2) We will define the mRNA (transcriptome) and protein (proteome) expression profiles of resting and
cytokine-activated NK cells, integrate these databases to define the mode of regulation of
molecules important during NK cell activation, and define the role of miRs for post-transcriptional
regulation.
Techniques utilized in the project include miR sequencing, miR microarrays, in vitro and in vivo
manipulation of miRs, the generation of a NK cell-specific Cre mouse model, the generation of genetic
mouse models deficient in miRs using Cre-Lox, and the global analysis of the NK cell transcriptome and
proteome. Washington University provides an ideal setting to train physician-scientists, and will foster an
invaluable mentored eduational experience for the PI to realize his career goals in academic medicine.
RELEVANCE (See instructions):
This overall career development proposal will train an independent physician-scientist for a lifetime of
research studying the immune system and cancer. As NK cells are key components of immunity to
numerous infectious pathogens, and are involved in the immunosurveillance of malignancy, the research
proposed may have far reaching consequences for health and disease. Specifically, a better understanding
of NK cell activation may lead to novel immune based stategies to treat hematologic malignancies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
-
批准号:9767734
-
项目类别:
-
资助金额:$59.58万
-
财政年份:2017
-
负责人:TODD A FEHNIGER
-
依托单位:
TRANSLATING NK CELL BIOLOGY INTO CLINICAL CANCER IMMUNOTHERAPY
-
批准号:10017898
-
项目类别:
-
资助金额:$61.42万
-
财政年份:2017
-
负责人:TODD A FEHNIGER
-
依托单位:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
-
批准号:10439627
-
项目类别:
-
资助金额:$32.89万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
-
批准号:8583090
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
-
批准号:8715686
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
-
批准号:8890768
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
-
批准号:10931079
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
-
批准号:10194404
-
项目类别:
-
资助金额:$27.62万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
MICRORNA REGULATION OF NK CELL DEVELOPMENT AND FUNCTION
-
批准号:9097519
-
项目类别:
-
资助金额:$38.0万
-
财政年份:2013
-
负责人:TODD A FEHNIGER
-
依托单位:
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
-
批准号:7810611
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:TODD A FEHNIGER
-
依托单位:
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
-
批准号:8032542
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:TODD A FEHNIGER
-
依托单位:
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
-
批准号:7659856
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:TODD A FEHNIGER
-
依托单位:
Molecular Mechanisms of Natural Killer Cell Cytokine-Activation
-
批准号:8427391
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2009
-
负责人:TODD A FEHNIGER
-
依托单位:
Project 5 - Memory-like NK cell augmented hematopoietic cell transplantation for AML.
-
批准号:9756325
-
项目类别:
-
资助金额:$31.91万
-
财政年份:--
-
负责人:TODD A FEHNIGER
-
依托单位:
海外基金